AU2024233883A1 - Immunoglobulin - Google Patents

Immunoglobulin

Info

Publication number
AU2024233883A1
AU2024233883A1 AU2024233883A AU2024233883A AU2024233883A1 AU 2024233883 A1 AU2024233883 A1 AU 2024233883A1 AU 2024233883 A AU2024233883 A AU 2024233883A AU 2024233883 A AU2024233883 A AU 2024233883A AU 2024233883 A1 AU2024233883 A1 AU 2024233883A1
Authority
AU
Australia
Prior art keywords
immunoglobulin
multimer
multimerization
deletion
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024233883A
Other languages
English (en)
Inventor
Reiko Shinkura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Publication of AU2024233883A1 publication Critical patent/AU2024233883A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2024233883A 2023-03-03 2024-03-04 Immunoglobulin Pending AU2024233883A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023033251 2023-03-03
JP2023-033251 2023-03-03
PCT/JP2024/008128 WO2024185747A1 (ja) 2023-03-03 2024-03-04 免疫グロブリン

Publications (1)

Publication Number Publication Date
AU2024233883A1 true AU2024233883A1 (en) 2025-09-25

Family

ID=92675164

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024233883A Pending AU2024233883A1 (en) 2023-03-03 2024-03-04 Immunoglobulin

Country Status (7)

Country Link
EP (1) EP4678662A1 (https=)
JP (2) JP7760200B2 (https=)
KR (1) KR20250158030A (https=)
CN (1) CN120826417A (https=)
AU (1) AU2024233883A1 (https=)
TW (1) TW202440928A (https=)
WO (1) WO2024185747A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0226878D0 (en) * 2002-11-18 2002-12-24 Univ Warwick Antibodies
JP5881034B2 (ja) 2011-03-01 2016-03-09 国立大学法人 東京大学 糸状菌変異株及びこれを用いたタンパク質の製造方法
JP5916946B2 (ja) 2013-03-11 2016-05-11 学校法人関西文理総合学園 モノクローナルＩｇＡ抗体の製造方法
US9261190B2 (en) 2013-03-14 2016-02-16 Federal-Mogul Corporation Low tension piston rings and method for manufacturing the same
JP6618463B2 (ja) * 2013-05-07 2019-12-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 三量体型抗原結合分子
JP6944697B2 (ja) 2017-05-16 2021-10-06 国立大学法人 東京大学 糸状菌におけるゲノム編集を用いる多段階による多重変異株の製造方法
JP2021110421A (ja) 2020-01-14 2021-08-02 トヨタ自動車株式会社 車両用油量調整装置
TW202202514A (zh) 2020-03-23 2022-01-16 日商東興藥品工業股份有限公司 多聚體ＩｇＡ抗體之製造法及多重特異性多聚體ＩｇＡ抗體
AU2021392318A1 (en) * 2020-12-03 2023-07-20 Zymeworks Bc Inc. Heterodimeric iga fc constructs and methods of use thereof
CA3224497A1 (en) 2021-07-01 2023-01-05 Reiko SHINKURA Antibody binding to clostridium difficile
US20240417450A1 (en) 2021-07-02 2024-12-19 The University Of Tokyo Monoclonal antibody-containing composition for suppressing clostridium difficile bacteria
EP4574840A1 (en) * 2022-08-15 2025-06-25 The University of Tokyo Method for producing immunoglobulin or multimer immunoglobulin using filamentous fungus

Also Published As

Publication number Publication date
EP4678662A1 (en) 2026-01-14
JP2025128156A (ja) 2025-09-02
JP7760200B2 (ja) 2025-10-27
TW202440928A (zh) 2024-10-16
KR20250158030A (ko) 2025-11-05
CN120826417A (zh) 2025-10-21
WO2024185747A1 (ja) 2024-09-12
JPWO2024185747A1 (https=) 2024-09-12

Similar Documents

Publication Publication Date Title
US20180009906A1 (en) METHOD FOR PRODUCING MONOCLONAL IgA ANTIBODY
JP7405386B2 (ja) クロストリジウム・ディフィシル菌に結合する抗体
Martinez-Maqueda et al. Casein hydrolysate and derived peptides stimulate mucin secretion and gene expression in human intestinal cells
EP3292145A1 (fr) MUTANTS Fc A ACTIVITÉ FONCTIONNELLE MODIFIÉE
EP4364755A1 (en) Monoclonal antibody-containing composition for suppressing clostridium difficile bacteria
Bhaskara et al. Efficient production of recombinant secretory IgA against Clostridium difficile toxins in CHO-K1 cells
JP6000130B2 (ja) 新規なシグナルペプチドおよび組換えタンパク質の生成のためのその使用
CA2533753C (en) Drug for cancer therapy
AU2024233883A1 (en) Immunoglobulin
EP4574840A1 (en) Method for producing immunoglobulin or multimer immunoglobulin using filamentous fungus
KR102037394B1 (ko) 신규한 크로노박터 사카자키 특이 박테리오파지 cs4 및 이를 포함하는 항균 조성물
CA3284842A1 (en) Immunoglobulin
US20230304023A1 (en) Bile salts bactosensor and use thereof for diagnostic and therapeutic purposes
Cohen et al. Mapping the homodimer interface of an optimized, artificial, transmembrane protein activator of the human erythropoietin receptor
EP4288566A1 (en) Bile salts bactosensor and use thereof for diagnostic and therapeutic purposes
CN103172694A (zh) 一种氨苄青霉素特异结合物的筛选方法及其用途
WO2024237217A1 (ja) クロストリジオイデス・ディフィシル菌に結合する抗体
US20250051426A1 (en) Composition containing monoclonal antibody
WO2025134928A1 (ja) 結腸直腸がんを治療するための組成物
US20230371536A1 (en) Protein having effect of improving immunostimulatory activity of exopolysaccharide of lactic acid bacteria, fermented milk using the same, and method for producing the same
CN120583960A (zh) 人源化抗hla-g嵌合抗原受体及其用途